lower gastrointestinal bleeding is a common cause for hospital admission that results in significant morbidity and mortality. After initial resuscitation of the patient, the diagnosis and treatment of lower gastrointestinal bleeding remains achallenge for acute care surgeons. Identifying the source of bleeding can be difficult since many patients bleed intermittentlyorstopbleeding spontaneously.Itistherefore importantfor theacute care surgeon to be familiar with the different diagnostic and therapeutic modalities and their advantages and disadvantages in order to guide the management of the acutely bleeding patient. this review summarizes the current methods available for the diagnosis and treatment of acute lower gastrointestinal bleeding and proposes an algorithm for the management of these patients.
Caring for these patients remains a challenge. Although up to 80% of patients will stop bleeding spontaneously,the recurrence rate reaches as high as 25%
(1, 5). Initial management decisions are based on hemodynamic status and resuscitation parameters. Dependent on severity,p atients may requirei nvasive monitoring techniques and admission to an ICU setting in order to be more effectively and rapidly stabilized. Once hemodynamic stability is achieved, the next priority is the identification of the source of bleeding. Once this is achieved, at reatment plan (conservative, endoscopic, or surgical) is delineated and implemented. In the few instances when hemodynamic stability is impossible to achieve, emergent laparotomy is performed in an attempt to identify the source of bleeding intraoperatively.
InITIAl MAnAGEMEnT
The initial workup of a patient with lGIB begins with determining hemodynamic stability.Borrowing from principles of Advanced Trauma life Support (ATlS), assessment of hemodynamic status by measurement of vital signs along with appropriate resuscitation measures should occur prior to any diagnostic stud-InTRODUCTIOn lower gastrointestinal bleeding (lGIB) is defined as hemorrhage that occurs beyond the ligament of Treitz. It is a frequent cause of hospital admission with an annual incidence of 20-30 cases per 100,000 population. It more commonly affects the elderly with an incidence as high as 200 per 100,000 population in the ninth decade of life (1). The rate of hospitalization also increases >200-fold between the third to ninth decade of life related to the increased incidence of diverticulosis and malignancy.M ortality rates can reach as high as 25%, especially in patients undergoing emergency surgery (2, 3). There is also a significant cost for the treatment of lGIB. Estimates show that in the US the cost to treat lGIB due to diverticular disease alone was over $1 billion in 2001 (4).
ies. Athorough history and physical exam should be performed while treatments are being applied including placement of large bore IVs as well as monitors if necessary.A ppropriate laboratory values should be ordered including a complete blood count, coagulation profiles, and blood gases. An initial type and screen should be completed in anticipation that blood transfusion may be required (6).
Anticoagulation therapy use is increasing every year in the US, especially among the elderly. Warfarin was the 18th most commonly prescribed drug in the US in 2006 (7). The physician should anticipate the possibility of transfusion of plasma to reverse anticoagulation therapy.T he successful use of activated recombinant factor VII has been described in the literature in several case reports (8-10). Its use is controversial and large studies have yet to be published. However, it can be considered when the use of plasma is potentially harmful to the patient or against their religious beliefs (11).
DIAGnOSIS AnD THERApy

DIAGnOSIS
Identification of the bleeding source remains a diagnostic challenge. Approximately 10% of all patients will never have asource identified and up to 40% of patients with lGIB have more than one potential bleeding source (12, 13) . Most patients stop bleeding spontaneously, therefore, it can be difficult to determine which source is the cause of the acute bleeding. Because massive upper gastrointestinal bleeding (UGIB) can masquerade as lGIB, initial evaluation should also include placement of an asogastric tube and gastric lavage along with esophagogastroduodenoscopy to identify apossible UGIB source.
In young adults, the most common causes include Meckel's diverticulum and inflammatory bowel disease (6). In a review of admissions due to lGIB, longstreth found that diverticulosis was the most frequent reason for hospital admission due to lGIB especially in the elderly (41.6%) (1). Colorectal malignancy and colitis werea lso common sources of bleeding in 9% and 14% respectively.I atrogenic causes included polypectomy and trauma due to colonoscopy while 12% of patients remained undiagnosed. Other common causes include angiodysplasias, mostly found in the right colon and in the elderly (14) . Infrequent causes include Crohn's disease, Meckel's diverticula, and small bowel tumors (15) .
The diagnostic approach to these patients is not standardized in most medical institutions (16) . In an attempt to facilitate triage of patients with lGIB, classification systems have been proposed that provide risk stratification according to the severity of bleeding. Strate et al. retrospectively reviewed patients admitted for lGIB and identified seven predictors of severe bleeding: heart rate ≥ 100, systolic blood pressure ≤ 115mmHg, syncope, non-tender abdominal exam, gross rectal bleeding, aspirin use, and >2 comorbidities (Table 1) (17) . patients with >3 risk factors had an 84% risk of severe bleeding defined as transfusion of >2units of red blood cells (18) . Classification systems, however,d on ot predict need or possibility for surgical or angiographic intervention.
Most diagnostic modalities are dependent on user skill and experience and may not be immediately available. Advances in technology have also expanded the scope of options for treatment of lGIB. It is thereforeimportant for the acute caresurgeon to be familiar with the different diagnostic and therapeutic modalities and their advantages in order to guide the management of the acutely bleeding patient (Table 2) . Colonoscopy has repeatedly shown to be safe, effective, and useful, especially when used in the first 12 to 24 hours of admission (12) . Complication rates are generally less than 3% and it has high diagnostic utility in identifying a source for lGIB (12, 19, 20) . Optimal timing for endoscopic examination has not been determined. However,recent work demonstrates that colonoscopy performed within the first 24 hours of admission may result in adefinitive diagnosis in up to 96% of patients (21) . These rates are improved with the moreaggressive use of bowel preparation agents which have been shown to be effective and safe even during acute bleeding (12, 22) . Earlyp reparation agents consisted of saline and mannitol solutions which were potentially hazardous in seriously ill patients. Currently Golytely ® , an electrolyte-polyethylene glycol colonic irrigation solution is the preferred agent. It allows for al arge volume lavage without clinically significant changes in electrolytes and fluid status (12, 23) .Green et al. compared urgent colonoscopy to a standard care algorithm which consisted of the use of technetium scans as well as angiography to localize the source of bleeding. When performed within 24 hours of presentation and after colonic preparation with apurgative, colonoscopy localized the source of lGIB in twice as many patients as standardprotocols (24) . With the continued advances in endoscopic technology, colonoscopy has become not only a diagnostic but also a useful therapeutic tool in the management of acute lGIB.
Early reports of successful coagulation in patients with non-bleeding visible vessels in diverticular disease encouraged moref requent use of this modality to treat lGIB (25) . Jensen et al., prospectively studied 10 patients with severe lGIB treated with endoscopic maneuvers. They found that endoscopic hemostasis was achieved in all 10 patients with no episodes of early re-bleeding. At 30 months follow-up, the incidence of late bleeding was 0% (22) . Ar eview performed by pilichos and Bobotis of all published series found a low complication rate as well as a low recurrence rate (< 10%) in patients treated with endoscopic methods (26) .
First used in the treatment of upper gastrointestinal bleeding, therea re several endoscopic methods whichc an be employed to obtain local hemostasis following lGIB including injection with adrenaline, mechanical clipping, and electrical coagulation. Injection therapy using adrenaline (1:10,000 concentration) is an effective hemostatic technique after endoscopic visualization of the bleeding source. It creates vasoconstriction,t amponade, and plateleta ggregation inducing hemostasis and it is effective when treating an actively bleeding vessel (27, 28) . Mechanical clipping utilizes metal clips, bands, and a variety of devices that apply mechanical compression on a bleeding vessel and is as uccessful method of hemostasis as well as am ethod of marking the location of the bleeding (29) .l astly,e lectrical coagulation using a bipolar probe is effective and safe in the treatment of the non-bleeding visible vessel (22, 25) .
However,t herea re disadvantages to endoscopy. Urgent colonoscopy is not always available. This method also requires large volume colonic purge for adequate clearing of the colon to increase the likelihood of bleeding site localization, which is not always tolerated by patients (12) . Successful localization as well as successful treatment varies between institutionsa nd larger studies have yet to be performed to demonstrate the overall efficacy of this treatment modality (26) . Colonoscopy is also an uncomfortable procedure, often requiring heavy sedation in order to completely visualize the lumen and identify the bleeding site (28) .
RADIOnUClIDE SCInTIGRApHy
In use since the 1970's, radionuclide scintigraphy involves either technetium-99m (Tc-99m) sulfur colloid or Tc -99m-labeled redb lood cells to localize bleeding from a gastrointestinal source. Sulfur colloid is easy to preparebut is cleared from the circulation quickly and therefore is not practical for serial and repeated scans. Radiolabeled redb lood cells maintain their activity for longer periods of time, allowing for serial imaging, giving better results when used to diagnose lGIB. Scintigraphy can identify bleeding as low as 0.1 ml/min and has been advocated as asafe, noninvasive, and accurate method identifying all types of gastrointestinal bleeding (30) . There is also no need for bowel preparation and repeat scans can be easily performed in cases of recurrent bleeding although limited by the half-life of the radiotracer used (31) .
Because scintigraphy is minimally invasive and well tolerated, it has been studied as am ethod of localization. However, this has been controversial. (32) The accuracy of the test for correctly localizing the site of bleeding ranges from 40% up to 100%. positivity correlates to the rate of bleeding as well as the length of time it takes for the scan to become positive (21, (32) (33) (34) . Because of this correlation, scintigraphy is now used at most institutions as a screening tool to determine the group of patients who would be optimal candidates for interventional angiography (35) . ng et al., found that patients with an immediate blush by scintigraphy had a high likelihood of localization by angiography. Gunderman et al., retrospectively reviewed their experience and found that scintigraphic screening increased the diagnostic yield of angiography by a factor of 2.4 (36) . negative scans may also be useful for screening as they are also associated with a low likelihood of requiring surgical intervention (37, 38) .
Despite its advantages, scintigraphy, however, is time intensive, dependent on availability,a nd is not therapeutic. Results of this test areoften inconsistent and dependent on operator experience. negative scans also do not imply a low rate of rebleeding. Hammond et al., found that overall, patients with negative scans had a rebleeding rate of 27% (38) . Scintigraphy should thereforebeused as ascreening tool to guide overall management and if interpreted conservatively, to guide surgical management (37) . AnGIOGRApHy First described in 1963, angiography is a useful technique in the diagnosis and treatment of lower gastrointestinal hemorrhage (39) .A lthough less sensitive than radionuclide scintigraphy,t his method allows for accurate localization of the source of bleeding at rates as low as 0.5 ml/min (30) . Arteriography provides a means of not only diagnosis but treatment as well. Several strategies have been used with angiography and include vasopressin infusion and embolization by several different methods.
Vasopressin infusion was first reported in 1968 to treat esophageal variceal hemorrhage (40) . This technique was soon adapted to treat gastrointestinal hemorrhage (41, 42) . Success rates have been reported from 59%-90% (43, 44) . While temporarily effective, recurrent bleeding rates when vasopressin is discontinued can reach 35%. Instead, vasopressin infusion is useful in controlling bleeding from vessels in the gastrointestinal tract that are not amenable to embolization (44) . Vasopressin should be considered when superselective embolization is unsuccessful with the goal of converting an emergent operation to an elective one.
Selective embolization for the treatment of acute upper gastrointestinal hemorrhage from a gastroepiploic artery was first described in 1972 (43) . Two years later, the first successful embolization using autogenous clot for lower gastrointestinal hemorrhage was reported (45) . First used to guide surgical therapy,a dvancesi ni nterventional radiology have expandedt he useo fa ngiography from diagnosis to treatment of acute lGIB.
The development of the coaxial microcatheter in the late 80's and of microcoil in the 90's expanded the role of angiography to provide therapeutic options for treating lGIB. The addition of finer guidewires led to the ability to deploy microcoils into specific mesenteric vessels allowing for superselective embolization (46) (47) (48) . While localization rates arestill low at 47%, when bleeding sites areidentified, successful embolization occurs in 86 to 100% of patients with complication rates as lowa s5 -10% (48) (49) (50) (51) (52) (53) . These include puncturesite complications including bleeding, hematoma, and pseudoaneurysm, as well as those associated with the administration of intravenous contrast dye. Overall, the most serious complication is bowel ischemia but with increasing experience and improving technology with superselective embolization, ischemia has become ar aree vent (50) .
provocative bleeding is an additional experimental method used by interventionalists to aid in the diagnosis of lGIB sources. When contrast fails to show the site of bleeding, this technique employs injection of thrombolytics to induce bleeding especially in cases of obscureb leeding wheret he source has not been identified by all other methods available (54) . This technique, however, is unreliable with successful induction of bleeding rates from 27% to 80% and localization results are inconsistent (54, 55) . While complication rates arelow,only afew studies have been reported (51) . It is also limited by intravenous con-trast exposure and the risk of contrast-induced nephropathy of up to 20% (56) .
MUlTI-DETECTOR ROW HElICAl COMpUTER TOMOGRApHy (MDCT)
Apromising technique in the localization of lGIB is the use of contrast-enhanced multi-detector row helical computed tomography scanning (MDCT). Compared to conventional CT, MDCT has the ability to dramatically increase resolution while decreasing scanning time. It allows for identification of extravasation of intraluminal contrast beforeitisdiluted by intestinal contents (57, 58) . This modality has been used increasingly in the diagnosis of vascular diseases as it is capable of more precise imaging and 3-D formatting of vascular structures. MDCT is noninvasive and easily performed with minimal risk to the patient when available (59) .
In comparison studies, MDCT demonstrates acute lower GI bleeding rates as low as 0.2ml/min, lower than that for angiography and comparable to radionuclide scanning (57, 60) . Overall rates of detection and localization range around 50-86% and are comparable to angiography (57, 61) . It is fast, relatively safe, and has been gaining more widespread availability.y oon et al., prospectively studied 26 patients who presented with acute massive GI bleeding. MDCT was able to show extravasation in 21 patients, of these 20 werefound to have evidence of bleeding at angiography.localization accuracy was also high with sensitivity and specificity rates of 91% and 99% respectively (58) .
It has also been proposed that MDCT may be a morereliable method of screening when compared to RBC scintigraphy.Zinc et al prospectively compared the use of MDCT and technetium-99m-labeled RBC scans to screen for patients who would benefit from angiography and possible embolization (61) . There was as tatistically significant disagreement between these two tests, with tagged RBC scans able to more reliably detect bleeding. In this study,a ll positive MDCT scans accurately localized the site of bleeding. MDCT does have multiple advantages over tagged RBC scan, including being non-invasive and giving improved anatomic detail of the area of hemorrhage.
More studies are required to determine the accuracy and role of this imaging method in the diagnosis of lGIB. The technology has been advancing rapidly with improvements in speed and imaging definition (62) . Its use is still limited by the need for intravenous contrast as well as the risks of increased radiation exposureassociated with the method (63) . However, with the advantages and more widespread use, MDCT may play a role in localization of lGIB, especially in centers where interventional radiology and endoscopy are not easily accessible. OTHERS push enteroscopy and capsule endoscopy have been investigated for the diagnosis of lGIB. push enteros-copy uses alonger,thinner endoscope to examine the small bowel but only reaches approximately 160 cm past the ligament of Treitz, leaving most of the small bowel unexamined (64) . This method, however, is uncomfortable for the patient and requires heavy sedation. It is not widely available and is dependent on operator skill for an adequate exam.
The improvements in wireless technology have paved the way for capsule endoscopy, a pill-sized capsule that the patient swallows and travels the entirelength of the GI tract by peristalsis. It is noninvasive and causes no patient discomfort. However,the test is purely diagnostic and time intensive, requiring at least 8 hours of fasting prior to the study. The capsule imaging is also limited by battery life, usually only 8hours. (64) In the acute setting, these methods have limited practicality and use. Both arelabor and time-intensive procedures, and areu ser or operator dependent. For both these methods, technological improvements may make these more viable options in the future but for now, do not play a role in the management of acute lGIB.
SURGICAl MAnAGEMEnT
Early studies of lGIB found that patients who were managed by "blind" subtotal colectomy experienced mortality rates as high as 25-33% (65, 66) . If at all possible, "blind" subtotal colectomy should be avoided because when bleeding is localized and segmental resection is performed, mortality decreases to approximately 7% (67) . However, in up to 25% of lGIB cases, emergency operation due to massive and severe hemorrhage is necessary. Criteria for emergency subtotal colectomyvaries between institutions but includes: greater than six units of blood transfusion in a24hour time period, hemodynamic instability, and inability to stabilize or localize by other interventions (68) .
Segmental resection as definitive management of lGIB should only occur once the site of bleeding has been localized. "Blind" segmental resection without localization is associated with a 57% mortality rate (69) . Although both colonoscopy and angiography have the advantages of being both diagnostic and potentially therapeutic modalities, in cases with continued or massive bleeding, surgical intervention is the definitive treatment. It is required in 20% of patients who bleed due to diverticular disease.
SOURCES OF BlEEDInG
DIVERTICUlAR DISEASE Colonic diverticular disease becomes increasingly common over the age of 40 and is present in up to 60% of patients over the age of 80. (70) The disease is responsible for 30% of lGIB but can be difficult to treat.
(1) Although most diverticula are found in the left colon, bleeding occurs from the right colon 50% of the time. lGIB due to diverticulosis spontaneously resolves in 90% of cases so it is difficult to localize the actual source of bleeding. When localized, these lesions respond well to avariety of treatment modalities. These lesions areamenable to adrenaline injection and contact coagulation with a rebleeding rate of 15% (6).
Traditional management for nonlocalized lGIB included a" blind subtotal colectomy" which carries a highmortality rate.(5) Resection without localization, however,isassociated with ahigh rebleeding rate up to42%. (69) We advocate thereforethat local resection should only be attempted after localization, either by endoscopy or angiography. Subtotal colectomy should be reserved in this disease for hemodynamically unstable patients without al ocalized source of bleeding.
AnGIODySplASIA
Angiodysplasias arec ommon sources of bleeding from the small intestine in patients over 50 years of age. Up to 6% of lGIB are due to lesions found in either thes mall or large bowel (1). Theya re most commonly found in the right colon and can be associated with disease states including CREST syndrome (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangectasia) and portal hypertension. Most patients experience intermittent or obscureb leeding which resolves in 90% of cases (6). When found, these lesions can be treated both endoscopically and with embolization. However, there are often multiple lesions and identifying the single bleeding lesion can be difficult (14) . If alesion is located in the right colon, a segmental resection may be helpful in managing the disease, provided that no small bowel lesions exist. However, examining the small bowel beyond the ligament of Treitz can be difficult. In this case, capsule endoscopy may be useful in examining the small bowel to rule out a small source of lGIB prior to segmental resection in hemodynamically stable patients in order to decrease the likelihood of rebleeding from a missed lesion (71) .
OTHERS
Other common causes of lGIB include malignancy and inflammatory bowel disease. Surgical treatment options should be guided by the specific disease that is encountered. If am alignancy is found, oncology principles should be followed to optimize apatient's prognosis. In cases of massive transfusion, surgical resection may have to take priority even in cases wherethe patient's cancer stage would typically call for neoadjuvant therapy. In patients with inflammatory bowel disease, massive transfusion may require immediate surgical resection to treat the acute lGIB when this disease is usually controlled with medications. In all cases, however, localization of bleeding remains the main goal to determine treatment.
We, therefore, propose the following algorithm in the diagnosis and management of lGIB (Fig. 1) . The key to the algorithm is the need for localization of the site of bleeding. Because of the dual benefit of localization with treatment, colonoscopy and angiography play an important role in the early management of lGIB. Even if these modalities fail to provide treatment, localization improves the likelihood of surgical intervention being successful.
SUMMARy
The diagnosis and treatment of lower gastrointestinal bleeding remains am edical challenge for surgeons. no standardized diagnostic protocol or treatment pathway has been accepted by medical professionals. Because of the differences in availability of clinician, endoscopic, and radiologic resources as well as experience with each modality,e ach medical institution has highly varying paths in the management of lGIB. It is therefore imperative that the acute care surgeon becomes familiar with what is available to them and the available user experience with each modality. Each has its own advantages and disadvantages. With evolving technology, the therapeutic options available to the patient allows for a decrease in mortality and morbidity as once emergent procedures are converted to semi-urgent or elective operations (72) . 
